33 results
8-K/A
EX-3.3
MYMD
MyMD Pharmaceuticals Inc
26 Mar 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-3.1
MYMD
MyMD Pharmaceuticals Inc
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-3.2
MYMD
MyMD Pharmaceuticals Inc
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-3.1
MYMD
MyMD Pharmaceuticals Inc
13 Feb 24
MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
4:57pm
8-K
EX-3.1
MYMD
MyMD Pharmaceuticals Inc
21 Feb 23
MyMD Announces $15 Million Offering with Existing Investors
9:00am
8-K
EX-3.1
8wsis m75
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
EX-3.3
yhq 58wh33
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
EX-3.2
j0z136
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
EX-3.1
chuzb94
9 Sep 20
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-3.1
5eys9w40tsckmwqpawee
27 Jul 20
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.1
dad5viw6nvm u1tikw
24 Mar 20
Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
9:21am
8-K
EX-3.1
7bao43 leb3u8o16a
6 Jan 20
Departure of Directors or Certain Officers
5:24pm
8-K
EX-3.1
k258c3
29 Nov 19
Amendments to Articles of Incorporation or Bylaws
6:15am